Dixon Hubard Feinour & Brown Inc Pfizer Inc Transaction History

Dixon Hubard Feinour & Brown Inc

$842 Million
Q2 2022

A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Pfizer Inc stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 120,468 shares of PFE stock, worth $3.35 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

120,468

Previous 122,678 1.8%

Holding current value

$3.35 Million

Previous $6.35 Million 0.55%

% of portfolio

0.75%

Previous 0.64%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $102,831 - $121,925	-2,210 Reduced 1.8%	120,468 $6.32 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $344,772 - $427,215	7,536 Added 6.54%	122,678 $6.35 Million
Q4 2021 Jan 10, 2022	BUY	$41.32 - $61.25 $586,248 - $869,015	14,188 Added 14.05%	115,142 $6.8 Million
Q3 2021 Oct 19, 2021	SELL	$39.25 - $50.42 $345,792 - $444,200	-8,810 Reduced 8.03%	100,954 $4.34 Million
Q2 2021 Aug 23, 2021	SELL	$35.91 - $40.68 $545,329 - $617,766	-15,186 Reduced 12.15%	109,764 $4.3 Million

Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $152,647 - $172,155	-4,558 Reduced 3.52%	124,950 $4.53 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $619,760 - $727,120	-19,520 Reduced 13.1%	129,508 $4.75 Million
Q2 2020 Jul 31, 2020	BUY	$30.12 - $36.54 $293,639 - $356,228	9,749 Added 7.0%	149,028 $5.82 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $23,975 - $34,255	-887 Reduced 0.63%	139,279 $4.55 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $479,809 - $544,522	-14,575 Reduced 9.42%	140,166 $5.49 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $30,833 - $39,981	949 Added 0.62%	154,741 $5.56 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $210,194 - $235,999	5,684 Added 3.84%	153,792 $6.66 Million
Q1 2019 May 17, 2019	BUY	$37.5 - $41.2 $184,012 - $202,168	4,907 Added 3.43%	148,108 $6.29 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $51,395 - $58,596	1,336 Added 0.94%	143,201 $6.25 Million
Q3 2018 Nov 06, 2018	BUY	$34.47 - $41.81 $58,771 - $71,286	1,705 Added 1.22%	141,865 $6.25 Million
Q2 2018 Jul 25, 2018	BUY	$32.98 - $35.16 $517,950 - $552,187	15,705 Added 12.62%	140,160 $5.09 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $195,002 - $226,229	-6,111 Reduced 4.68%	124,455 $4.42 Million
Q4 2017 Feb 20, 2018	BUY	$33.26 - $35.29 $64,025 - $67,933	1,925 Added 1.5%	130,566 $4.73 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $3.99 Million - $4.39 Million	128,641	128,641 $4.59 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.

Account

Dixon Hubard Feinour & Brown Inc Pfizer Inc Transaction History